Cargando…
Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
The clinical outcomes of hepatocellular carcinoma (HCC) remain dismal. Elucidating the molecular mechanisms for the progression of aggressive HCC holds the promise for developing novel intervention strategies. The transactivation response element RNA-binding protein (TRBP/TARBP2), a key component of...
Autores principales: | Li, Li-Man, Chen, Chang, Ran, Ruo-Xi, Huang, Jing-Tao, Sun, Hui-Lung, Zeng, Chang, Zhang, Zhou, Zhang, Wei, Liu, Song-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265608/ https://www.ncbi.nlm.nih.gov/pubmed/34249676 http://dx.doi.org/10.3389/fonc.2021.620912 |
Ejemplares similares
-
Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
por: Li, Li-Man, et al.
Publicado: (2021) -
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
por: Lai, Hui‐Huang, et al.
Publicado: (2019) -
TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019) -
SUMOylation of TARBP2 regulates miRNA/siRNA efficiency
por: Chen, Cheng, et al.
Publicado: (2015) -
Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
por: Caramuta, Stefano, et al.
Publicado: (2013)